Moderna and IBM said they will explore using artificial intelligence, blockchain and hybrid cloud technologies, among others, to improve COVID-19 vaccine management, according to a March 4 news release.
The partnership is aiming to provide two things in vaccine management:
1. End-to-end traceability to address potential supply chain disruptions, which would enable governments and healthcare providers to share data on individual vaccine batches throughout the supply chain.
2. Digital Health Pass, utilizing blockchain technology, to share information with organizations on test results, vaccination records and temperature checks.
To read the full news release, click here.
More articles on data analytics:
International healthcare research groups create common model to share data
Pew: 4 ways updating health data exchange methods would improve public health
3 major healthcare groups push for better race, ethnicity data reporting during COVID-19 vaccination
© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.